What is the interpretation and clinical significance of an echocardiogram showing normal left ventricular systolic function with visual ejection fraction 55–60%, normal left ventricular size, mild asymmetric left ventricular hypertrophy, normal global wall motion, normal diastolic filling pattern, normal right ventricular size and function, trace aortic regurgitation, and possibly a bicuspid aortic valve?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Echocardiogram Interpretation: Mild Asymmetric LVH with Possible Bicuspid Aortic Valve

This echocardiogram shows overall reassuring findings with normal cardiac function, but requires close surveillance for two key features: the mild asymmetric left ventricular hypertrophy and the possibly bicuspid aortic valve, both of which carry long-term implications despite current normal function.

Key Findings and Clinical Significance

Left Ventricular Function and Structure

  • Normal systolic function with EF 55-60% indicates preserved contractility 1
  • Mild asymmetric LVH warrants investigation for underlying causes (hypertension, athletic remodeling, or genetic cardiomyopathy) 2
  • The asymmetric pattern (rather than concentric) suggests either early hypertensive changes, physiologic adaptation, or potentially hypertrophic cardiomyopathy phenotype 1
  • Normal diastolic filling is favorable, as diastolic dysfunction typically accompanies pathologic LVH and predicts adverse outcomes 3

Valvular Findings

Possibly Bicuspid Aortic Valve (BAV):

  • This finding requires definitive confirmation with dedicated imaging, as BAV carries significant lifetime implications 4, 5
  • If confirmed, BAV patients require lifelong surveillance even with trace regurgitation, as they are at risk for progressive valve dysfunction, aortopathy (ascending aortic dilatation), infective endocarditis, and rarely aortic dissection 4
  • Trace aortic regurgitation is currently hemodynamically insignificant (annual risk of progression to symptoms/LV dysfunction <6%, sudden death <0.2%) 6

Right Heart

  • Normal RV size and function with no evidence of pulmonary hypertension is reassuring 1

Recommended Clinical Actions

Immediate Workup

  1. Confirm BAV diagnosis with either:

    • High-quality transthoracic echo with focused parasternal short-axis views in systole (looking for two commissures and elliptical orifice) 7
    • If echo inconclusive, obtain ECG-gated cardiac CT or cardiac MRI for definitive valve morphology assessment 4, 5
  2. Evaluate LVH etiology:

    • Blood pressure assessment (ambulatory monitoring if office readings borderline) 8
    • Family history of cardiomyopathy or sudden cardiac death
    • Consider cardiac MRI if asymmetric pattern suggests hypertrophic cardiomyopathy 3
  3. Measure ascending aorta dimensions comprehensively:

    • If BAV confirmed, obtain dedicated imaging of entire thoracic aorta (CT angiography or MRI) to assess for aortopathy 4, 5
    • BAV patients commonly develop ascending aortic dilatation requiring surgical intervention independent of valve dysfunction

Surveillance Strategy

If BAV confirmed with trace AR:

  • Echocardiography every 6-12 months initially to establish stability of valve function and LV dimensions 6
  • Annual imaging of ascending aorta (echo acceptable if <45mm; CT/MRI if ≥45mm or inadequate visualization) 4
  • Monitor for progression of AR severity, development of stenosis, or aortic dilatation

For mild asymmetric LVH:

  • Repeat echo in 6-12 months to assess for progression 2
  • If hypertension identified, optimize control and reassess LV mass after treatment
  • If athletic, consider detraining study to distinguish physiologic from pathologic hypertrophy

Prognostic Implications

Current risk profile is low given:

  • Preserved EF and normal diastolic function
  • Only trace valvular regurgitation
  • Normal RV function

However, long-term vigilance required because:

  • BAV patients have cumulative lifetime risk of valve complications requiring intervention in 30-50% 4
  • Mild LVH, even when asymptomatic, independently predicts cardiovascular events when inappropriately elevated for hemodynamic load 2
  • The combination of BAV and LVH may indicate early hemodynamic stress from the valve abnormality 9, 10

Common Pitfalls to Avoid

  1. Do not dismiss "possibly bicuspid" - this requires definitive confirmation as management differs substantially from tricuspid valves 4
  2. Do not assume LVH is benign - asymmetric patterns warrant exclusion of hypertrophic cardiomyopathy, especially if family history positive 1
  3. Do not neglect aortic imaging - if BAV confirmed, the aorta requires equal attention to the valve itself, as aortopathy may require intervention even with normal valve function 5
  4. Avoid using trace AR to dismiss BAV significance - the valve morphology matters more than current hemodynamics for long-term risk 4

671312245

References

Related Questions

What is the appropriate management for a 56-year-old female with concentric left ventricular hypertrophy, mild global left ventricular hypokinesia (involving the left anterior descending territory), left ventricular ejection fraction 50%, mild aortic and mitral regurgitation, grade I diastolic dysfunction, recent resolved chest pain, hypertension, and a single kidney?
What level and type of physical activity is safe for a patient with a congenital bicuspid aortic valve, based on valve function and ascending aortic size?
How does mild concentric left‑ventricular hypertrophy contribute to end‑organ damage in a patient with chronic diastolic dysfunction, low end‑diastolic volume, low stroke‑volume index, and heart‑failure with preserved ejection fraction physiology?
What is the management plan for a patient with mild concentric left ventricular hypertrophy, normal left ventricular systolic function, severely dilated left atrium, moderately to severely dilated right atrium, mild valvular aortic stenosis, and trace to mild valvular regurgitation?
Can you explain the echocardiogram findings (mild concentric left ventricular hypertrophy, ejection fraction 60‑65%, apical akinesis, mild aortic valve regurgitation, normal other chambers) in simple terms and recommend appropriate management?
What is the cause of low B-type natriuretic peptide (BNP) levels in obese patients?
Is intravenous tissue-type plasminogen activator (tPA) safe for an adult with acute ischemic stroke who has taken clopidogrel (Plavex) within the past 24 hours, and how should antiplatelet therapy be managed?
What does a non‑fasting urine osmolality of 129 mOsm/kg indicate and how should it be evaluated?
In a patient with normal serum sodium and low non‑fasting urine osmolality, what is the most likely diagnosis and what are the recommended next steps?
What is the recommended duration of treatment with oseltamivir (Tamiflu) for influenza in adults?
What is the interpretation of an echocardiogram showing normal left ventricular systolic function with visual ejection fraction 55‑60 %, normal left ventricular wall thickness and global wall motion, indeterminate diastolic filling pattern, mildly dilated left atrial cavity (36.4 ml/m²), normal right ventricular size and function, aortic valve sclerosis, mild mitral valve leaflet thickening, trace tricuspid regurgitation, and right ventricular systolic pressure 19 mmHg?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.